Xiu-Feng Wang1, Qian-Mei Zhou, Yi-Yu Lu, Hui Zhang, Shuang Huang, Shi-Bing Su. 1. Shanghai University of Traditional Chinese Medicine, Research Center for Traditional Chinese Medicine Complexity System , Shanghai 201203 , China +86 215 132 3013 ; shibingsu07@163.com.
Abstract
INTRODUCTION: Radix Glycyrrhiza has been used in China for thousand years to treat cancer. However, focus on its tumor-suppressing mechanism has been concentrated on its effect on tumor cell growth and apoptosis. OBJECTIVES: With the aid of a panel of human breast cancer cell lines, we reveal that glycyrrhetinic acid (GA), a major component of Radix Glycyrrhiza, is actually a significantly more potent agent to suppress invasion than cell survival. RESULTS: GA effectively inhibits breast cancer cell MMP-2/MMP-9 expression; GA-induced reduction in the MMP-2/9 expression is apparently mediated by GA's ability to specifically inhibit the p38 MAPK activity and its downstream AP1 activation. Moreover, we show that GA down regulates the levels of Fra-1 and c-Jun, two main components of AP1 transcription complex in invasive breast cancer cells and that AP1-specific inhibitor abrogates breast cancer cell invasion. These results suggest that GA impairs the p38 MAPK-AP1 signaling axis, leading to the repression of breast cancer cell invasion. Finally, we demonstrate that GA effectively suppresses breast tumor outgrowth and pulmonary metastasis without causing animal weight loss or eliciting liver/kidney toxicity to the recipient animals. CONCLUSION: This study indicates that GA represents a good candidate compound for the potential development of therapeutic drug.
INTRODUCTION: Radix Glycyrrhiza has been used in China for thousand years to treat cancer. However, focus on its tumor-suppressing mechanism has been concentrated on its effect on tumor cell growth and apoptosis. OBJECTIVES: With the aid of a panel of humanbreast cancer cell lines, we reveal that glycyrrhetinic acid (GA), a major component of Radix Glycyrrhiza, is actually a significantly more potent agent to suppress invasion than cell survival. RESULTS:GA effectively inhibits breast cancer cell MMP-2/MMP-9 expression; GA-induced reduction in the MMP-2/9 expression is apparently mediated by GA's ability to specifically inhibit the p38 MAPK activity and its downstream AP1 activation. Moreover, we show that GA down regulates the levels of Fra-1 and c-Jun, two main components of AP1 transcription complex in invasive breast cancer cells and that AP1-specific inhibitor abrogates breast cancer cell invasion. These results suggest that GA impairs the p38 MAPK-AP1 signaling axis, leading to the repression of breast cancer cell invasion. Finally, we demonstrate that GA effectively suppresses breast tumor outgrowth and pulmonary metastasis without causing animal weight loss or eliciting liver/kidney toxicity to the recipient animals. CONCLUSION: This study indicates that GA represents a good candidate compound for the potential development of therapeutic drug.
Entities:
Keywords:
MMP; breast cancer; glycyrrhetinic acid; invasion; p38 MAPK
Authors: Daniel J de Klerk; Mark J de Keijzer; Lionel M Dias; Jordi Heemskerk; Lianne R de Haan; Tony G Kleijn; Leonardo P Franchi; Michal Heger Journal: Methods Mol Biol Date: 2022
Authors: Nipin S P; Pramod Darvin; Young Beom Yoo; Youn Hee Joung; Dong Young Kang; Don Nam Kim; Tae Sook Hwang; Sang Yoon Kim; Wan Seop Kim; Hak Kyo Lee; Byung Wook Cho; Heui Soo Kim; Kyung Do Park; Jong Hwan Park; Soung Hoon Chang; Young Mok Yang Journal: BMC Cancer Date: 2015-06-19 Impact factor: 4.430